Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAT-DUTA AndroCoV Trial
NCT04729491Phase 3Completed
- Sponsor
- Corpometria Institute
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Dutasteride Arm with Placebo Arm (2 arms). Primary endpoint: Positivity rate of rtPCR-SARS-CoV-2 at Day 7. Started Jun 2020; status: completed.
02
Drugs
dutasteride
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04729491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729491.